Joe.My.God. LGBT News
CNN reports:
The FDA could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the growing body of evidence that shows their monoclonal therapies don’t effectively neutralize the virus’ Omicron variant. The NIH had recently updated its guidelines to advise clinics against using these treatments on patients with mild to moderate Covid-19 due to their diminished effectiveness against the Omicron variant.
Earlier this month, amid a record-breaking surge of new coronavirus cases in Florida, Gov. Ron DeSantis assailed the Biden administration for pausing shipments of the monoclonal antibodies, and has pushed for the treatment to remain widely available. During a January 3 press conference, DeSantis contended his administration had seen the treatments work on Omicron patients, though he didn’t provide further evidence.
Read the full article.
“Regeneron has publicly stated its monoclonal antibody treatment is not effective against the Omicron variant.
Nearly 13,000 doses of Regeneron were used in Florida over the past two weeks, more than any three other states combined.” https://t.co/eksmT80rgh
— Melissa Ross (@MelissainJax) January 23, 2022
Florida Gov. Ron DeSantis Opens Monoclonal Antibody Centers That Are Useless Against Omicron https://t.co/2IZc187kn5
— Daniel Uhlfelder (@DWUhlfelderLaw) January 19, 2022